NuVasive
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, NuVasive sits in the top decile of US sponsors by registered trial count (#568 of 15,742 sponsors by registered trial count).
NuVasive: 28 sponsored US clinical trials, none currently recruiting.
NuVasive sponsors 28 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 27 completed. 3 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Degenerative Disc Disease, with 4 trials.
Top-decile sponsor footprint
NuVasive ranks in the top decile of sponsors by registered trial count (#568 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
27 of 27 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
28 total, page 1 of 1
Long-term Assessment of the Safety and Performance of the NuVasive Simplify Disc
NCT05258435
Retrospective Modulus ALIF Study
NCT05566704
Post Approval Study Protocol for the Two Level Simplify® Cervical Artificial Disc
NCT04980378
XLIF Decade Plate System Study
NCT04689880
Post-Approval Study Protocol for the Simplify Cervical Artificial Disc
NCT04630626
MSK Validation Study
NCT04422288
Modulus in XLIF Study
NCT04418817
MLX/XLX ACR Expandable Lumbar Interbody Implants
NCT04420143
Investigation of the Two Level Simplify® Cervical Artificial Disc
NCT03123549
Comprehensive Spinal Alignment Planning Study
NCT02606695
Investigation of the Simplify® Cervical Artificial Disc
NCT02667067
Advanced XLIF Monitoring Multicenter Study
NCT02272140
Advanced XLIF Monitoring Pilot Study
NCT02192112
Post-Approval Clinical Trial of the PCM® Cervical Disc
NCT01905930
A Prospective Non-concurrent Controlled Evaluation of Open and MAS® PLIF
NCT01640977
Multimodality Neuromonitoring in XLIF
NCT01499680
SpineTRACK Registry - Spinal Outcomes Registry
NCT01372592
An Evaluation of Interlaminar Lumbar Instrumented (ILIF™)
NCT01019057
XLIF® vs. MAS®TLIF for the Treatment of Symptomatic Lumbar Degenerative Spondylolisthesis With or Without Central Stenosis.
NCT01024699
XL TDR® eXtreme Lateral Total Disc Replacement for the Treatment of Lumbar Degenerative Disc Disease (DDD)
NCT00927238
Osteocel® Plus in Posterior Lumbar Interbody Fusion (PLIF)
NCT00941980
Osteocel® Plus in Transforaminal Lumbar Interbody Fusion (TLIF)
NCT00947583
Osteocel® Plus in Anterior Lumbar Interbody Fusion (ALIF)
NCT00948831
NeuroVision® Dynamic Screw Test Study
NCT01232517
Osteocel® Plus in eXtreme Lateral Interbody Fusion (XLIF®)
NCT00948532
Osteocel® Plus in Anterior Cervical Discectomy and Fusion (ACDF)
NCT00942045
Evaluating The Safety and Effectiveness of The NeoDisc™ Versus ACDF in Subjects With Single-Level Cervical Disc Disease
NCT00478088
PCM Cervical Disc System
NCT00578812
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 3 |
How the NuVasive archive is shaped
28 indexed studies, none listed as recruiting (0% open); 27 completed (96%).
Phase mix: 3 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Degenerative Disc Disease (4 trials), 7 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
NuVasive: archived-pipeline peers nationwide
Peers matched on 28 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
NuVasive sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 28 archived trials
- Axsome Therapeutics · 28 trials · 21% recruiting
- Benaroya Research Institute · 28 trials · 14% recruiting
- CAMC Health System · 28 trials · 11% recruiting
- CTI BioPharma · 28 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this NuVasive page
28 registered trials is a research-attention snapshot, not an endorsement of NuVasive or any single study.
- None of NuVasive's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Degenerative Disc Disease is the condition NuVasive studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Degenerative Disc Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
NuVasive pipeline card: 28 registered trials from official public datasets.Report a data error.